New drug - Toctino
Basilea has launched Toctino (alitretinoin) for the treatment of severe chronic hand eczema (CHE) in... Read more
Figures released last week show that practices have improved on their QOF scores for the third year ... Read more
NHS staff are used to upheaval and change. Some times this change brings problems and difficulties, ... Read more
Although the final extended hours directed enhanced service (DES) has yet to be published, the DoH h... Read more
Polyclinics are either the panacea to the NHS's ills or a threat to the very future of primary care,... Read more
Last week the government announced it is to hold a six-month debate on the future of care and suppor... Read more
What a difference two years can make. In 2006, the then health secretary Patricia Hewitt was forced ... Read more
Last month it was announced that one of the final barriers to nurse prescribing is to be scrapped (I... Read more
Recent years have seen huge changes in the way many NHS services are delivered, but it seems that th... Read more
The DoH set out its vision of an expanded role for primary care nurses in 2002's Liberating the Tale... Read more
At the time of writing it seems that GPs will vote to accept the revised extended hours directed enh... Read more
Quick search - use * for an abbreviated search, eg nico*
Basilea has launched Toctino (alitretinoin) for the treatment of severe chronic hand eczema (CHE) in... Read more
UCB Pharma has launched Vimpat (lacosamide) for adjunctive therapy in the treatment of partial-onset... Read more
Firazyr (icatibant acetate) is indicated for the symptomatic treatment of acute attacks of hereditar... Read more